ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 559

$1.12M Total Retail Price of All Prescriptions

Rank: 1 out of 559

1,338 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 1,338 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 1,338 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 17,035 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 1,450 1,007 1 2
LISINOPRIL 1,196 808 2 1
HYDROCODONE-ACETAMINOPHEN 998 520 S3 3 7
METFORMIN HCL 775 518 4 5
SIMVASTATIN 738 554 5 3
FUROSEMIDE 580 420 6 11
OMEPRAZOLE 563 292 7 4
GABAPENTIN 492 220 8 9
IBUPROFEN 478 199 9 30
AMLODIPINE BESYLATE 475 327 10 6
HYDROCHLOROTHIAZIDE 451 270 11 8
OXYCODONE-ACETAMINOPHEN 409 250 S2 12 44
GLIMEPIRIDE 407 270 13 53
LOVASTATIN 402 270 14 10
POTASSIUM CHLORIDE 365 273 15 23
ZOLPIDEM TARTRATE 343 214 16 17
TAMSULOSIN HCL 329 283 17 25
CEPHALEXIN 307 182 18 80
METOPROLOL TARTRATE 298 245 19 12
GEMFIBROZIL 294 167 20 71
METOPROLOL SUCCINATE 292 278 21 16
TRAZODONE HCL 270 135 22 28
PROAIR HFA 266 131 23 29
ALLOPURINOL 244 172 24 34
CITALOPRAM HBR 232 128 25 21
CIPROFLOXACIN HCL 220 140 26 60
CYCLOBENZAPRINE HCL 219 49 R 27 54
LOSARTAN POTASSIUM 204 193 28 14
WARFARIN SODIUM 201 159 29 24
ATENOLOL 197 125 30 15
DOXYCYCLINE HYCLATE 195 121 31 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 191 163 32 18
FELODIPINE ER 190 177 33 72
LANTUS 189 144 34 40
MELOXICAM 177 127 35 42
TRAMADOL HCL 176 80 36 27
SERTRALINE HCL 166 51 37 19
ATORVASTATIN CALCIUM 166 123 37 20
CELEBREX 165 125 39 86
CLOTRIMAZOLE-BETAMETHASONE 155 92 40 182
DONEPEZIL HCL 153 131 41 36
ROPINIROLE HCL 153 83 41 95
CYMBALTA 152 80 43 78
RANITIDINE HCL 150 90 44 26
ADVAIR DISKUS 143 80 45 46
FLUTICASONE PROPIONATE 142 67 46 22
ALENDRONATE SODIUM 142 119 46 13
BACLOFEN 140 63 48 90
PAROXETINE HCL 138 45 49 48
AZITHROMYCIN 135 85 50 39
OXYCODONE HCL-ACETAMINOPHEN 126 56 S2 51 70
OXYBUTYNIN CHLORIDE 126 41 51 62
SPIRIVA 126 91 51 67
NEXIUM 124 27 54 57
PREDNISONE 123 60 55 49
CARISOPRODOL 119 0 R 56 73
SPIRONOLACTONE 118 93 57 74
PHENYTOIN SODIUM EXTENDED 118 74 57 123
INSULIN SYRINGE 117 93 59 65
PANTOPRAZOLE SODIUM 115 82 60 41
CRESTOR 115 112 60 33
FLUOXETINE HCL 113 56 62 37
KLOR-CON M20 111 88 63 103
FINASTERIDE 108 108 64 59
GLIPIZIDE 106 75 65 31
AMITRIPTYLINE HCL 105 34 R 66 58
CLARITHROMYCIN 104 51 67 207
JANUVIA 99 78 68 50
NAMENDA 98 98 69 56
OXYCODONE HCL 98 52 S2 69 32
FAMOTIDINE 98 54 69 93
PLAVIX 97 72 72 76
CLOPIDOGREL 95 60 73 51
HYDROXYZINE HCL 95 49 R 73 108
ACETAMINOPHEN-CODEINE 93 57 S3 75 83
PREMARIN 92 39 R 76 97
CARVEDILOL 92 68 76 38
DIGOXIN 92 78 76 94
METRONIDAZOLE 89 44 79 212
CLONIDINE HCL 88 64 80 68
NOVOLOG 86 41 81 155
GLYBURIDE 86 77 R 81 45
NOVOLIN 70-30 85 41 83 137
ESCITALOPRAM OXALATE 84 72 84 109
FLUCONAZOLE 83 44 85 215
DOXAZOSIN MESYLATE 82 42 86 43
DILTIAZEM ER 81 70 87 118
LOSARTAN-HYDROCHLOROTHIAZIDE 80 48 88 52
TERBINAFINE HCL 72 42 89 223
NAPROXEN 70 45 90 79
KLOR-CON M10 70 60 90 140
TRIAMCINOLONE ACETONIDE 70 48 90 84
TIZANIDINE HCL 67 0 93 166
GLIPIZIDE ER 66 47 94 77
VENTOLIN HFA 66 38 94 113
PREMPRO 65 0 R 96 228
AMLODIPINE BESYLATE-BENAZEPRIL 64 40 97 110
FENOFIBRATE 63 53 98 69
TRICOR 63 54 98 142
NEOMYCIN-POLYMYXIN-DEXAMETH 63 39 98 232
ESTRADIOL 63 19 R 98 117
BUPROPION HCL SR 61 36 102 114
NYSTATIN 58 33 103 197
BENAZEPRIL-HYDROCHLOROTHIAZIDE 58 28 103 147
SYNTHROID 58 46 103 64
QUETIAPINE FUMARATE 58 36 103 135
LEVETIRACETAM 57 29 107 149
DILTIAZEM 24HR CD 56 56 108 152
LUNESTA 55 39 109 245
FLOVENT HFA 55 26 109 129
MIRTAZAPINE 54 39 111 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 24 111 96
INDOMETHACIN 53 21 R 113 249
CLINDAMYCIN HCL 52 19 114 254
PRISTIQ ER 52 34 114 209
CARBIDOPA-LEVODOPA 50 50 116 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.